A RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFECT OF VIRECHANA KARMA AND TRUSHNADI LOHA, LEKHANA BASTI AND TRUSHNADI LOHA AND DIET MANAGEMENT IN DYSLIPIDEMIA

DR ASHWINI0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年11月21日

研究概览

暂无简介。

•1) Subjects of Dyslipidemia who have Total Cholesterol: 200-239 mg/dl, Serum Triglycerides:
•150-499 mg/dl, Elevated Low Density Lipoprotein: 100-189 mg/dl53
•, Low or Normal High
•Density Lipoprotein: 35-59 mg/dl and Very Low Density Lipoprotein: >30mg/dl.
•2) Patientâ??s having variations in any or all components of Lipid Profile will be taken for studies
•3) Subjects irrespective of gender.
•4) Subjects between the age group 25-60 years.
•5) Subjects who are fit for Virechana Karma in Virechana intervention group.
•6) Subjects who are fit for Lekhana Basti in Basti intervention group.
•7) Diagnosed i.e., the patients who are already on Statins and fresh cases of Dyslipidemia will be
•taken for the study. The definition of fresh cases includes:
•ï?· Freshly detected and untreated cases of Dyslipidemia.
•ï?· Established and treated cases of Dyslipidemia who have voluntarily discontinued the
•treatment for at least 2 weeks before the case could be taken.
•ï?· Established and treated cases of Dyslipidemia for whom treatment will be stopped and flush
•out period of 2 weeks will be allowed before intervention.

•1) Subjects having any systemic disorders which can interfere with the intervention.
•2) Pregnant & Lactating women.
•3) Alcoholic subjects will be excluded.

发起方

DR ASHWINI